Overview A First Time in Human Study in Healthy Volunteers and Patients Status: Completed Trial end date: 2016-03-01 Target enrollment: Participant gender: Summary A multi-part study to investigate the safety, tolerability and local and systemic pharmacokinetics of V565 Phase: Phase 1 Details Lead Sponsor: VHsquared Ltd.